PL2437762T3 - Sztuczne łzy i ich zastosowania terapeutyczne - Google Patents
Sztuczne łzy i ich zastosowania terapeutyczneInfo
- Publication number
- PL2437762T3 PL2437762T3 PL10724631T PL10724631T PL2437762T3 PL 2437762 T3 PL2437762 T3 PL 2437762T3 PL 10724631 T PL10724631 T PL 10724631T PL 10724631 T PL10724631 T PL 10724631T PL 2437762 T3 PL2437762 T3 PL 2437762T3
- Authority
- PL
- Poland
- Prior art keywords
- therapeutic uses
- artificial tears
- tears
- artificial
- therapeutic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18433909P | 2009-06-05 | 2009-06-05 | |
EP10724631.6A EP2437762B1 (en) | 2009-06-05 | 2010-06-03 | Artificial tears and therapeutic uses |
PCT/US2010/037153 WO2010141648A2 (en) | 2009-06-05 | 2010-06-03 | Artificial tears and therapeutic uses |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2437762T3 true PL2437762T3 (pl) | 2018-01-31 |
Family
ID=42312750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL10724631T PL2437762T3 (pl) | 2009-06-05 | 2010-06-03 | Sztuczne łzy i ich zastosowania terapeutyczne |
Country Status (24)
Country | Link |
---|---|
US (6) | US8496976B2 (pl) |
EP (1) | EP2437762B1 (pl) |
KR (1) | KR101778316B1 (pl) |
CN (2) | CN102458430A (pl) |
AU (1) | AU2010256652B2 (pl) |
BR (1) | BRPI1011710B8 (pl) |
CA (1) | CA2764802A1 (pl) |
DK (1) | DK2437762T3 (pl) |
ES (1) | ES2646338T3 (pl) |
HK (1) | HK1214943A1 (pl) |
HR (1) | HRP20171691T1 (pl) |
HU (1) | HUE034213T2 (pl) |
IL (1) | IL216800A (pl) |
LT (1) | LT2437762T (pl) |
MX (2) | MX358504B (pl) |
MY (1) | MY172185A (pl) |
NO (1) | NO2437762T3 (pl) |
NZ (1) | NZ596932A (pl) |
PL (1) | PL2437762T3 (pl) |
PT (1) | PT2437762T (pl) |
RU (1) | RU2589837C2 (pl) |
SI (1) | SI2437762T1 (pl) |
WO (1) | WO2010141648A2 (pl) |
ZA (1) | ZA201108979B (pl) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8569367B2 (en) | 2004-11-16 | 2013-10-29 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
CN102458430A (zh) | 2009-06-05 | 2012-05-16 | 阿勒根公司 | 人工泪液及治疗用途 |
US8957048B2 (en) * | 2011-10-06 | 2015-02-17 | Allergan, Inc. | Compositions for the treatment of dry eye |
US9907826B2 (en) | 2011-12-07 | 2018-03-06 | Allergan, Inc. | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
SI2787969T1 (sl) * | 2011-12-07 | 2021-12-31 | Allergan, Inc. | Učinkovita dostava lipidov v solzni film človeka z uporabo na sol občutljivega emulzijskega sistema |
US9278132B2 (en) * | 2012-02-13 | 2016-03-08 | Bausch & Lomb Incorporated | Ophthalmic pharmaceutical compositions and methods of making and using same |
WO2013142912A1 (en) * | 2012-03-30 | 2013-10-03 | Brien Holden Vision Institute | Methods and compositions for reducing ocular discomfort |
US9289494B2 (en) * | 2013-11-20 | 2016-03-22 | RestorTears, LLC | Method of treating ocular disorders with compounds found in Harderian gland secretions |
US9394355B2 (en) | 2014-08-20 | 2016-07-19 | Silk Technologies, Ltd. | Fibroin-derived protein composition |
MX2017006474A (es) * | 2014-11-25 | 2017-09-12 | Allergan Inc | Composiciones oftalmicas estabilizadas de omega 3. |
EP3362096B1 (en) | 2015-10-14 | 2023-12-13 | Paul Gavaris | Ophthalmic treatment composition and vehicle for delivery of pharmaceutical substances or therapeutic agents |
KR20190008210A (ko) | 2016-04-08 | 2019-01-23 | 코넬 유니버시티 | 실크 유래 단백질을 이용한 상처 치료를 증가시키는 방법 |
PL3266446T3 (pl) * | 2016-07-07 | 2019-05-31 | Salvat Lab Sa | Kompozycja oftalmiczna zawierająca olej rycynowy i trójgliceryd o średniej długości łańcucha |
AU2017310520A1 (en) | 2016-08-12 | 2019-03-21 | Silk Technologies, Ltd. | Silk-derived protein for treating inflammation |
WO2018035469A1 (en) * | 2016-08-19 | 2018-02-22 | Akrivista, LLC | Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye |
GB201618175D0 (en) * | 2016-10-27 | 2016-12-14 | Warneford Healthcare Ltd | Pharmaceutical compositions |
CN110996964A (zh) * | 2017-06-30 | 2020-04-10 | 杰尼视界公司 | 用于毛发生长的制剂 |
CN111295169A (zh) | 2017-08-18 | 2020-06-16 | 阿克里维斯塔有限责任公司 | 诊断和治疗干眼综合症的方法和用于治疗人类眼睛的组合物 |
KR20210038636A (ko) | 2018-07-27 | 2021-04-07 | 존슨 앤드 존슨 서지컬 비전, 인코포레이티드 | 눈 치료용 조성물 및 방법 |
BR112021000634A2 (pt) | 2018-07-27 | 2021-04-06 | Johnson & Johnson Surgical Vision, Inc. | Composições e métodos para tratar os olhos |
EP3829614A2 (en) | 2018-07-27 | 2021-06-09 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
US11197841B2 (en) | 2019-07-23 | 2021-12-14 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
US10966948B2 (en) | 2019-07-23 | 2021-04-06 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
US11166997B2 (en) | 2018-07-27 | 2021-11-09 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
WO2020021481A1 (en) | 2018-07-27 | 2020-01-30 | Johnson & Johnson Vision Care, Inc. | Compositions and methods for treating the eye |
US11110051B2 (en) | 2018-08-30 | 2021-09-07 | Johnson & Johnson Consumer Inc. | Topical compositions comprising Pichia anomala and n-acetyl glucosamine |
US11045416B2 (en) | 2018-08-30 | 2021-06-29 | Johnson & Johnson Consumer Inc. | Topical compositions comprising Pichia anomala and retinol |
KR20210009947A (ko) | 2019-07-18 | 2021-01-27 | 윤영선 | 산소가 도입된 점안제, 및 그 제조방법 |
US11969451B2 (en) | 2019-11-19 | 2024-04-30 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
US11969454B2 (en) | 2019-11-19 | 2024-04-30 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
CN112823789B (zh) | 2019-11-19 | 2024-05-10 | 强生外科视力公司 | 用于治疗眼睛的组合物和方法 |
EP3824877A1 (en) | 2019-11-19 | 2021-05-26 | Johnson & Johnson Consumer Inc. | Compositions and methods for treating the eye |
EP4059508A1 (en) | 2021-03-19 | 2022-09-21 | Johnson & Johnson Consumer Inc. | Methods of using compositions comprising an iceland moss extract |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56104814A (en) * | 1980-01-25 | 1981-08-20 | Kunihiro Okanoe | Preparation of eye drop |
US4649047A (en) | 1985-03-19 | 1987-03-10 | University Of Georgia Research Foundation, Inc. | Ophthalmic treatment by topical administration of cyclosporin |
JPH0667850B2 (ja) | 1987-09-03 | 1994-08-31 | ユニバーシティ オブ ジョージア リサーチ ファウンデーション,インコーポレイテッド | 眼科用サイクロスポリン組成物 |
US4839342A (en) | 1987-09-03 | 1989-06-13 | University Of Georgia Research Foundation, Inc. | Method of increasing tear production by topical administration of cyclosporin |
BE1003578A4 (fr) * | 1988-10-26 | 1992-04-28 | Sandoz Sa | Nouvelles compositions ophtalmiques a base d'une cyclosporine. |
US5474979A (en) * | 1994-05-17 | 1995-12-12 | Allergan, Inc. | Nonirritating emulsions for sensitive tissue |
AU1172097A (en) | 1995-12-27 | 1997-07-28 | Rohto Pharmaceutical Co., Ltd. | Pharmaceutical composition containing trehalose |
US5981607A (en) * | 1998-01-20 | 1999-11-09 | Allergan | Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers |
GB0012597D0 (en) | 2000-05-25 | 2000-07-12 | Astrazeneca Ab | Formulation |
US7027446B2 (en) | 2001-07-18 | 2006-04-11 | P-Cube Ltd. | Method and apparatus for set intersection rule matching |
JP4284491B2 (ja) | 2002-07-16 | 2009-06-24 | 豊和工業株式会社 | ピストン外形の加工データ生成装置 |
UY28126A1 (es) * | 2002-12-24 | 2004-06-30 | Alcon Inc | Uso de glucocorticoides selectivos para la superficie ocular en el tratamiento de la sequedad ocular |
KR20120066688A (ko) * | 2003-02-24 | 2012-06-22 | 파마슈티칼 프로덕션스, 인크. | 경점막 약물 전달 시스템 |
US20060251685A1 (en) | 2003-03-18 | 2006-11-09 | Zhi-Jian Yu | Stable ophthalmic oil-in-water emulsions with Omega-3 fatty acids for alleviating dry eye |
US20040185068A1 (en) | 2003-03-18 | 2004-09-23 | Zhi-Jian Yu | Self-emulsifying compositions, methods of use and preparation |
US20060009522A1 (en) | 2004-07-01 | 2006-01-12 | Reza Dana | Compositions and methods for treating eye disorders and conditions |
JPWO2006022291A1 (ja) * | 2004-08-27 | 2008-05-08 | 千寿製薬株式会社 | ドライアイ治療用点眼液 |
US8569367B2 (en) | 2004-11-16 | 2013-10-29 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
CN100562340C (zh) * | 2005-06-17 | 2009-11-25 | 中国科学院上海药物研究所 | 一种微乳型人工泪液 |
US7297679B2 (en) | 2005-07-13 | 2007-11-20 | Allergan, Inc. | Cyclosporin compositions |
US7202209B2 (en) | 2005-07-13 | 2007-04-10 | Allergan, Inc. | Cyclosporin compositions |
US7288520B2 (en) | 2005-07-13 | 2007-10-30 | Allergan, Inc. | Cyclosporin compositions |
WO2008035246A2 (en) | 2006-07-28 | 2008-03-27 | Novagali Pharma Sa | Compositions containing quaternary ammonium compounds |
WO2008027341A2 (en) * | 2006-08-30 | 2008-03-06 | Merck & Co., Inc. | Topical ophthalmic formulations |
EP2131809A2 (en) * | 2007-02-28 | 2009-12-16 | Aciex Therapeutics, Inc. | Methods and compositions for normalizing meibomian gland secretions |
CN101554369B (zh) * | 2008-05-12 | 2012-07-25 | 陈亚玲 | 一种外用复合油纳米乳喷雾剂和滴眼剂及其制备方法 |
UA36915U (uk) * | 2008-05-28 | 2008-11-10 | Львівський Національний Медичний Університет Ім. Данила Галицького | Очні краплі для лікування запальних захворювань судинної оболонки та сухого кератокон'юнктивіту, які викликані аутоімунними процесами |
IT1393419B1 (it) | 2009-03-19 | 2012-04-20 | Medivis S R L | Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6. |
US9480645B2 (en) | 2009-06-02 | 2016-11-01 | Abbott Medical Optics Inc. | Omega-3 oil containing ophthalmic emulsions |
CN102458430A (zh) | 2009-06-05 | 2012-05-16 | 阿勒根公司 | 人工泪液及治疗用途 |
-
2010
- 2010-06-03 CN CN2010800348429A patent/CN102458430A/zh active Pending
- 2010-06-03 AU AU2010256652A patent/AU2010256652B2/en active Active
- 2010-06-03 EP EP10724631.6A patent/EP2437762B1/en not_active Revoked
- 2010-06-03 NO NO10724631A patent/NO2437762T3/no unknown
- 2010-06-03 RU RU2011151468/15A patent/RU2589837C2/ru active
- 2010-06-03 MX MX2014012100A patent/MX358504B/es unknown
- 2010-06-03 CN CN201510225116.XA patent/CN104906170A/zh active Pending
- 2010-06-03 US US13/376,374 patent/US8496976B2/en active Active
- 2010-06-03 PT PT107246316T patent/PT2437762T/pt unknown
- 2010-06-03 WO PCT/US2010/037153 patent/WO2010141648A2/en active Application Filing
- 2010-06-03 DK DK10724631.6T patent/DK2437762T3/da active
- 2010-06-03 PL PL10724631T patent/PL2437762T3/pl unknown
- 2010-06-03 LT LTEP10724631.6T patent/LT2437762T/lt unknown
- 2010-06-03 NZ NZ596932A patent/NZ596932A/en unknown
- 2010-06-03 MX MX2011013007A patent/MX2011013007A/es active IP Right Grant
- 2010-06-03 BR BRPI1011710A patent/BRPI1011710B8/pt active IP Right Grant
- 2010-06-03 SI SI201031575T patent/SI2437762T1/en unknown
- 2010-06-03 HU HUE10724631A patent/HUE034213T2/en unknown
- 2010-06-03 ES ES10724631.6T patent/ES2646338T3/es active Active
- 2010-06-03 CA CA2764802A patent/CA2764802A1/en not_active Abandoned
- 2010-06-03 KR KR1020127000233A patent/KR101778316B1/ko active IP Right Grant
- 2010-06-03 MY MYPI2012000497A patent/MY172185A/en unknown
-
2011
- 2011-12-06 IL IL216800A patent/IL216800A/en active IP Right Grant
- 2011-12-07 ZA ZA2011/08979A patent/ZA201108979B/en unknown
-
2013
- 2013-06-28 US US13/931,281 patent/US8679554B2/en active Active
-
2014
- 2014-01-28 US US14/166,589 patent/US9821020B2/en active Active
-
2016
- 2016-03-14 HK HK16102876.7A patent/HK1214943A1/zh unknown
-
2017
- 2017-10-23 US US15/791,158 patent/US11045515B2/en active Active
- 2017-11-06 HR HRP20171691TT patent/HRP20171691T1/hr unknown
-
2021
- 2021-05-25 US US17/329,586 patent/US20220008496A1/en not_active Abandoned
-
2023
- 2023-08-03 US US18/364,692 patent/US20240108677A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1214943A1 (zh) | 人工淚液及治療用途 | |
IL220261A0 (en) | Intraocular devices and associated methods | |
IL214797A0 (en) | Lacrimal implants and related methods | |
GB2472856B (en) | IL1-RAP modulators and uses thereof | |
IL218212A0 (en) | Therapeutic methods and compositions | |
ZA201109034B (en) | Aminopyrrolidinone derivatives and uses thereof | |
IL213974A0 (en) | Isoxazole-isoxazole and isoxazole-isothiazole derivatives | |
SI2483292T1 (sl) | Variantni polipeptidi lovd in njihove uporabe | |
EP2339668A4 (en) | BATTERY AND BATTERY UNIT | |
EP2268281A4 (en) | THIENOPYRROLES AND PYRROLOTHIAZOLES AS NEW THERAPEUTIC AGENTS | |
ZA201201287B (en) | Therapeutic aryl-amido-aryl compounds and their use | |
EP2269612A4 (en) | EYE DROP PREPARATION AND ITS USE | |
PT2563806E (pt) | Leucolectinas humanas e suas utilizações | |
GB2460178B (en) | Depsipeptides and their therapeutic use | |
EP2427129A4 (en) | DEVICES AND METHODS FOR MODIFYING FABRICS | |
GB0912744D0 (en) | Methods and uses | |
EP2461870A4 (en) | THERAPEUTIC COMPOSITIONS AND METHOD | |
GB0905970D0 (en) | Depsipeptides and their therapeutic use | |
GB0809329D0 (en) | Depsipeptides and their therapeutic use | |
GB0903145D0 (en) | Medicaments uses and methods | |
GB0910620D0 (en) | Agents and uses thereof | |
GB0913955D0 (en) | Lactams and their therapeutic use | |
GB0920904D0 (en) | Uses and methods | |
GB0906043D0 (en) | Nalmefene compositions and their therapeutic use | |
GB0906046D0 (en) | Nalmefene compositions and their therapeutic use |